Dr. Caleb Jeon, MD

Dr. Jeon practices at Facey Medical Group in Burbank, California.

Dr. Jeon's NPI, 1528558160, was assigned on May 17, 2018. Dr. Jeon graduated from John A. Burns School of Medicine in 2018. Dr. Jeon holds California license 163750.

Dr. Jeon's primary practice is Facey Medical Group, at 191 S Buena Vista St Suite 100 Suite 100, Burbank, CA 91505-4562. The practice phone is (818) 869-7600.

Dr. Jeon's primary practice is Facey Medical Group in Burbank, California. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Jeon to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jeon practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Jeon's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Jeon is board certified in dermatology by the American Board of Dermatology. Dr. Jeon is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Jeon treats.

CMS data shows 1,278 Medicare services from Dr. Jeon across 9 procedure codes in 2024, for 459 Medicare patients. Medicare paid $63,943 for them. Every service was in an office.

CMS counts 459 Medicare patients who saw Dr. Jeon in 2024. The largest group is 65 to 74, with 195 patients. 69% of them have high cholesterol, and 62% have high blood pressure. 12% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jeon's median patient age at 50, with 58% women.

In 2024, Dr. Jeon wrote 736 Medicare Part D claims for 262 patients. 87% of them were for generic drugs. CMS names the drug for 615 of them, across 15 drugs with 11 or more claims each, at $600,146 in total drug cost. In 2023, CMS named 803 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Jeon for performance year 2024, reported as part of a group. Dr. Jeon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 85 procedures of removal of skin lesions by Dr. Jeon, more than 74% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Dr. Jeon, published from 2017 to 2024. 2017 was the busiest year, with 14. The most frequent topics are Psoriasis, Delusional Parasitosis and Phototherapy. Dr. Jeon has published most often in Dermatol Ther (Heidelb). Dr. Jeon's most frequent co-authors are Wilson Joe Liao, MD, Sahil Singh Sekhon, MD and John Y.m. Koo, MD.

CMS Open Payments shows 69 general payments to Dr. Jeon from 12 drug and device companies from 2020 to 2024. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $869.

Dr. Jeon graduated from John A. Burns School of Medicine in 2018.

Dr. Jeon is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.